Inactive Instrument

Allergan, Inc. Share Price

Stocks

US0184901025

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

07/17/07	Allergan : Mylan defends chairman to ISS ahead of June 22 investor vote	RE
02/17/02	Allergan : U.S. state, local government lawsuits over opioids face uphill battle	RE

Latest news: Allergan, Inc.

07/17/07	Allergan : Mylan defends chairman to ISS ahead of June 22 investor vote	RE
02/17/02	Allergan : U.S. state, local government lawsuits over opioids face uphill battle	RE
16/17/16	Allergan : Several top fund managers trim Allergan stakes in first quarter	RE
16/17/16	Icahn takes new 19.8 million share stake in Conduent in first quarter	RE
13/17/13	Allergan : High-profile Snap stakeholders revealed in filings	RE
13/17/13	Allergan : High-profile Snap stakeholders revealed in filings	RE
09/17/09	Allergan : posts loss as it writes down Teva holdings	RE
09/17/09	Allergan : posts loss as it writes down Teva holdings	RE
09/17/09	Takeda Pharmaceutical : Sanofi pegs U.S. drug price rises to below healthcare inflation	RE
22/17/22	Allergan : Collapse of Kraft-Unilever tie-up extends run of failed mega-deals	RE
14/17/14	Allergan : to buy fat-fighter Zeltiq Aesthetics for $2.48 billion	RE
13/17/13	Allergan : Stada to hold takeover talks with rival suitors Cinven and Advent	RE
08/17/08	Allergan : says U.S. tax reform unlikely in 2017, sees strong year	RE

Press Releases: Allergan, Inc.

07/17/07	Allergan : to Present New Data on Chronic Migraine at the American Headache Society Meeting in Boston	PU
31/17/31	Allergan : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans	PU
24/17/24	Allergan : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) Cream, 1%	PU
16/17/16	Allergan : Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications	PU
04/17/04	Allergan : to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego	PU

More press releases

News in other languages: Allergan, Inc.

12/17/12	Aktien New York: Dow schwächelt erneut - Einzelhandel im Fokus
12/17/12	Aktien New York Ausblick: Erneut moderate Verluste - Einzelhandel im Fokus
11/17/11	WDH/Aktien New York: Dow schwächer - Enttäuschende Unternehmenszahlen
11/17/11	Aktien New York Ausblick: Dow leicht im Minus - Quartalszahlen-Desaster bei Snap
10/17/10	Aktien New York: Leichte Einbußen im frühen Handel

Managers and Directors: Allergan, Inc.

Manager	Title	Age	Since
Scott Reents PSD	President	59	-

Director	Title	Age	Since
Scott Reents BRD	Director/Board Member	59	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+2.70%	+0.35%	+40.67%	+110.31%	1,03200Cr
	JOHNSON & JOHNSON	+1.44%	-3.41%	+37.36%	+63.95%	61TCr
	ABBVIE INC.	+1.75%	+3.07%	+17.89%	+83.05%	47TCr
	MERCK & CO., INC.	+0.60%	-4.35%	+60.80%	+37.46%	35TCr
	ROCHE HOLDING AG	+2.92%	+3.06%	+24.83%	+45.10%	34TCr
	NOVARTIS AG	+2.42%	-0.74%	+13.44%	+35.80%	27TCr
	ASTRAZENECA PLC	+1.86%	-0.81%	-4.69%	+12.20%	25TCr
	AMGEN INC.	+2.60%	-2.49%	+40.45%	+54.44%	22TCr
	GILEAD SCIENCES, INC.	+1.82%	-2.93%	+29.29%	+96.48%	18TCr
	Average	+1.79%	-3.39%	+28.89%	+59.87%	41.28TCr
	Weighted average by Cap.	+1.95%	-3.18%	+32.16%	+70.59%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!